Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Rocky Mountain Ayre Inc RMTN

Healthcare
Rocky Mountain Ayre Inc is a holding company. It is engaged in producing BitLocation. It is a software platform that will provide ordinary currency exchange offices, shops, and other retail businesses a virtually no-cost, no-risk way to buy and sell cryptocurrencies, and become cryptocurrency locations.

Recent & Breaking News (GREY:RMTN)

Dr. Gregory Sullivan to join Rocky Mountain Ayre, Inc.

Marketwired October 4, 2017

Rocky Mountain Ayre Clarifies Kairos Statement

Marketwired October 3, 2017

$150 million: Crypto Asset fund offers Tokenized Securities ICO

Marketwired August 22, 2017

Summit Reports Positive Phase 1 Data and Outlines Route to Market Strategy for DMD Candidate Ezutromid

Hugin August 9, 2016

HSBC Bank Plc : Form 8.5 (EPT/RI) - London Stock Exchange Group Plc

Hugin August 9, 2016

Summit Reports Positive Phase 1 New Formulation Data and Outlines Route to Market Strategy for DMD Candidate Ezutromid

GlobeNewswire August 9, 2016

Summit Therapeutics to Present at Canaccord Genuity Growth Conference

GlobeNewswire August 5, 2016

Summit Therapeutics plc : Result of AGM

Hugin July 18, 2016

Summit Therapeutics plc : Exercise of Options

Hugin June 28, 2016

Summit Therapeutics plc : Award of Options

Hugin June 24, 2016

NB Glbl Fltg Rte Inc : Transaction in Own Shares

Hugin June 24, 2016

Tern Plc : Acquisition

Hugin June 24, 2016

Summit's Ridinilazole Preserves Microbiome During Treatment of C. Difficile Infection

Hugin June 21, 2016

NB Glbl Fltg Rte Inc : Transaction in Own Shares

Hugin June 21, 2016

Afarak Group: Change of Adviser

Hugin June 21, 2016

Summit’s Ridinilazole Preserves Microbiome During Treatment of C. Difficile Infection

GlobeNewswire June 20, 2016

Summit Therapeutics plc : Notice of AGM

Hugin June 17, 2016

First Patient Enrolled in Summit's PhaseOut DMD, a Phase 2 Clinical Trial of Ezutromid in Boys with DMD

Hugin June 17, 2016

First Patient Enrolled in Summit’s PhaseOut DMD, a Phase 2 Clinical Trial of Ezutromid in Boys With DMD

GlobeNewswire June 17, 2016

Summit Therapeutics to Present at JMP Securities Life Sciences Conference

GlobeNewswire June 16, 2016